Structure/Function Studies of the Androgen Receptor DNA-Binding Region
Final addendum 1 Apr 2003-31 Mar 2004
VIRGINIA UNIV CHARLOTTESVILLE
Pagination or Media Count:
The androgen receptor AR regulates the growth and differentiation of prostate cells and is an important drug target for prostate cancer chemotherapy. The research goals associated with this study are to characterize the structural and functional aspects of the AR in order to uncover the potential of its domains, and in particular the DNA-binding domain, as a drug target. In this final report that includes the addendum period one year no-cost extension, I discuss the results obtained over the three year course of the funding, plus the additional no cost extension period of one year, towards characterization of the AR and related proteins. Among our findings are a the DNA- binding domain of the androgen receptor and related nuclear receptors act as their nuclear export signals, b their export is dependent on their binding to the protein calreticulin in the presence of calcium, c by analogy with our recent crystal structure of EcR-Usp on DNA, a pair of DNA-binding domains are arranged symmetrically as a homodimer with respect to each other and directly on the half-sites of their target DNA, and the proteins are subject to substantial plasticity in their DNA contacts, and d the ligand binding domain is analogous to the FXR ligand-binding domain and shares highly related surfaces responsible for DHT binding and coactivator binding.
- Genetic Engineering and Molecular Biology
- Anatomy and Physiology
- Medicine and Medical Research